Nano X Imaging (NNOX) - 76.98% Below 52-Week High: Buy or Wait?

Stock Details

Nano X Imaging Ltd (NNOX), a prominent company in the healthcare sector within the medical devices industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $1.31. Over the past 52 weeks, it has ranged between $0.73 and $5.69. This places the current price at 23.0% of its 52-week high and 78.5% above its 52-week low. Recent trading volume was recorded at 10. The 14-day Relative Strength Index (RSI) stands at 41.57, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $1.71 by 23.39%. Similarly, it is below its 200-day moving average of $2.76 by 52.54%. The MACD histogram is -0.03, indicating bearish momentum (MACD Line: -0.17, Signal Line: -0.14). There are currently 2 active alerts set for NNOX by users.

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

0.75

EV/EBITDA

-7.41

EPS (TTM)

-$1.15

Price to Sales

6.23

Beta

1.23

Similar volatility to market

Q:How is NNOX valued relative to its earnings and growth?

Valuation data is not available for this stock.

Q:What is NNOX's risk profile compared to the market?

With a beta of 1.23, Nano X Imaging Ltd is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.75 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-337.00%

EBITDA

$-49,509,000

Return on Equity

-50.10%

Return on Assets

-22.30%

Revenue Growth (YoY)

53.10%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is NNOX's business model?

0 The operating margin of -337.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -50.10% and ROA at -22.30%, the company achieves moderate returns on invested capital.

Q:What are NNOX's recent growth trends?

Nano X Imaging Ltd's revenue grew by 53.10% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against MEDICAL DEVICES industry averages for proper context.

Company Size & Market

Market Cap

$90.5M

Revenue (TTM)

$14.52M

Revenue/Share (TTM)

$0.22

Shares Outstanding

69.60M

Book Value/Share

$2.01

Asset Type

Common Stock

Q:What is NNOX's market capitalization and position?

Nano X Imaging Ltd has a market capitalization of $90.5M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 69.60M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DEVICES industry, it competes with other firms in this sector.

Q:How does NNOX's price compare to its book value?

Nano X Imaging Ltd's book value per share is $2.01, while the current stock price is $1.31, resulting in a price-to-book (P/B) ratio of 0.65. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$5.80

342.75% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

Q:How reliable are analyst predictions for NNOX?

3 analysts cover NNOX with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $5.80 implies 342.7% upside, but targets are often adjusted to follow price moves rather than predict them.

Q:What is the Wall Street consensus on NNOX?

Current analyst recommendations:03 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 5, 2026, 02:04 AM

Technical Indicators

RSI (14-day)

41.57

Neutral

50-Day Moving Average

$1.71

-23.39% below MA-50

200-Day Moving Average

$2.76

-52.54% below MA-200

MACD Line

-0.17

MACD Signal

-0.14

MACD Histogram

-0.03

Bearish

Q:What does NNOX's RSI value tell investors?

The RSI (Relative Strength Index) for NNOX is currently 41.57, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.

Q:How should traders interpret NNOX's MACD and moving average crossovers?

MACD analysis shows the MACD line at -0.17 below the signal line at -0.14, with histogram at -0.03. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.71) is below the 200-day MA ($2.76), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Jul 5, 2026, 12:54 AM

Condition	Threshold	Created At
Price rises above	$3.75	Jan 25, 2026, 06:27 PM
Golden Cross	N/A	Jan 25, 2026, 06:26 PM

Condition

Threshold

Created At

Price rises above

$3.75

Jan 25, 2026, 06:27 PM

Golden Cross

N/A

Jan 25, 2026, 06:26 PM

Nano X Imaging Ltd (NNOX) Stock